Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?

Volume: 22, Issue: 19, Pages: 10629 - 10629
Published: Sep 30, 2021
Abstract
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumor of the skin whose incidence is rising. Multimodal treatment is crucial in the non-metastatic, potentially curable setting. However, the optimal management of patients with non-metastatic MCC is still unclear. In addition, novel insights into tumor biology and newly developed treatments (e.g., immune checkpoint inhibitors) that dramatically improved outcomes in the advanced setting...
Paper Details
Title
Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?
Published Date
Sep 30, 2021
Volume
22
Issue
19
Pages
10629 - 10629
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.